Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock.

Aspira Women’s Health Trading Up 2.2 %

AWH opened at $0.10 on Tuesday. The stock’s 50-day moving average price is $0.23 and its 200 day moving average price is $0.59. Aspira Women’s Health has a 12-month low of $0.08 and a 12-month high of $3.63. The firm has a market cap of $1.70 million, a price-to-earnings ratio of -0.08 and a beta of 1.57.

Aspira Women’s Health (NASDAQ:AWH) last issued its quarterly earnings results on Thursday, March 27th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.13. The business had revenue of $2.35 million for the quarter, compared to analyst estimates of $3.00 million.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. raised its stake in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 316,294 shares of the company’s stock after purchasing an additional 79,898 shares during the period. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $256,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 12.19% of the stock is owned by institutional investors and hedge funds.

About Aspira Women’s Health

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.